European Union
International Standa...
NGOs
United Nations
Anguilla
Antigua & Barbuda
Aruba
Bahamas
Barbados
Belize
Bermuda
British Virgin Islands
Cayman Islands
Costa Rica
Cuba
Dominica
Dominican Republic
El Salvador
Grenada
Guadeloupe
Guatemala
Haiti
Honduras
Jamaica
Martinique
Montserrat
Netherlands Antilles
Nicaragua
Panama
Puerto Rico
St. Kitts & Nevis
St. Lucia
St. Vincent & the Gr...
Trinidad & Tobago
Turks & Caicos Islands
US Virgin Islands
|
SomaliaScientific Committee on Consumer Products (SCCP)
| Report Title: |
Preliminary Opinion on Safety of Nanomaterials in Cosmetic Products |
| Report ID: |
191 |
| Date: |
6/19/2007 |
| Author: |
Scientific Committee on Consumer Products (SCCP) |
| Report Type: |
Committee Report |
| URL: |
[sccp_o_099.pdf] |
| Country: |
European Union |
| Organization: |
Scientific Committee on Consumer Products (SCCP) |
| Summary: |
Following a report by the UK Royal Society and Royal Academy of Engineering which suggested treating nanomaterials as new chemicals and questioned the suitability of mass-based standards for assessing toxicological risks, the European Communitys Scientific Committee on Consumer Products (SCCP) was requested to examine the safety of nanomaterials in cosmetic products. These materials are either labile (disintegrating upon skin contact into their molecular components) or insoluble (such as titanium dioxide in sunscreen). Insoluble nanoparticles are the primary cause of concern for human safety. This committee report examines possible health concerns and exposure routes of these nanoparticles. The existing in vitro technique for estimating skin absorption may not be applicable to nanoscale materials, and the committee suggests that new methodologies are needed. One major problem is the need for in vivo testing to determine nanoparticle concentrations in organs, because of the ban upon animal testing for cosmetic products. |
| Archived Copy: |
SCCP (2007), Preliminary opinion on safety of nano_191_8431.pdf |
 |
|
| Report Title: |
The SCCP'S Notes of Guidance for the Testing of Cosmetic Ingredients and Their Safety Evaluation, 6th Revision |
| Report ID: |
164 |
| Date: |
12/19/2006 |
| Author: |
European Union, Scientific Committee on Consumer Products |
| Report Type: |
Guidance Document |
| URL: |
[sccp_o_03j.pdf] |
| Country: |
European Union |
| Organization: |
Scientific Committee on Consumer Products (SCCP) |
| Summary: |
The document contains relevant information on the different aspects of testing and safety evaluation of cosmetic ingredients. It is designed to provide guidance to public authorities and cosmetic industry, in order to improve harmonized compliance with Directive 76/768/EEC 1 and in particular by the Sixth (Dir. 93/35/EEC) and Seventh (Dir. 2003/15/EC3) Amendments to this Directive. The "Notes of Guidance" are regularly revised and updated in order to incorporate the progress of scientific knowledge in general, and the experience gained in particular, in the field of testing and safety evaluation of cosmetic ingredients. Since the last revision, several new opinions of importance to the content of this guidance document have been adopted and they form the basis of this new revision. The Notes of Guidance should not be seen as a checklist, but have been compiled to provide assistance in the complex process of the testing and safety evaluation of cosmetic ingredients. As was also the case in the previous revision, individual SCCP opinions are not provided in detail, but are briefly summarized and clearly referred to. The revisions contained in this document focus on cosmetic products, with particular emphasis placed on testing guidelines and safety assessments.
|
| Archived Copy: |
sccp_o_03j_164_5464.pdf |
|
|
| Report Title: |
Preliminary Opinion on Safety of Nanomaterials in Cosmetic Products |
| Report ID: |
77 |
| Date: |
6/19/2007 |
| Report Type: |
General Report |
| URL: |
[risk_en.htm] |
| Country: |
Other |
| Organization: |
Scientific Committee on Consumer Products (SCCP) |
| Summary: |
This opinion is a response by the SCCP to questions regarding the safety of nanomatierals in cosmetic products, the implications on animal testing, and whether previous opinions about nanomaterials currently used in sunscreen products would need to be revised. The opinion indicated that conventional risk assessment methodologies may be adequate for labile nanoparticles. However, it mentioned that primary health concerns involve insoluble particles but are inconclusive due to insufficient information at this time. Furthermore, the opinion stresses the need for new methodologies to assess percutaneous penetration pathways because evidence indicates that mechanical and/or chemical action on the skin may have an effect on nanoparticles penetration. This opinion also stated that large data gaps exist in the risk assessment of nanoparticles used in cosmetic products that are inhaled and ingested. In regards to animal testing, the opinion stated that only validated “in vitro” methods may be tested on animals, but currently there are no validated “in vitro” methods for nanomaterials. Finally, the opinion found that due to the considerable increase in available scientific data on nanosized particles it is necessary to review safety of nanomaterials currently used in sunscreen products. |
|
|
|